4 things to know about the Abarca/LucyRx merger.
The article focuses on the planned merger between Abarca, a pharmacy benefit manager (PBM) specializing in Medicare, Medicaid, and commercial health plans, and LucyRx, a PBM serving self-insured employers, labor groups, and specialty care networks. The merger, expected to finalize in the third quart...
| Publicado en: | Formulary Watch pp. 1 - 2 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
6/19/2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195380647&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 195380647 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 27673359 MD2F jtl: Formulary Watch issn: 27673359 maglogo: N pubinfo: dt: 6/19/2026 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 195380647 195380647 ppf: 1 ppct: 1 formats: tig: atl: 4 things to know about the Abarca/LucyRx merger. aug: au: Myshko, Denise sug: subj: Mergers and Acquisitions United States Health Care Industry Insurance, Pharmaceutical Services United States Artificial Intelligence Utilization Decision Making, Clinical Leadership Health Insurance Exchanges Audit Reimbursement Mechanisms Medicare Medicaid Digital Technology ab: The article focuses on the planned merger between Abarca, a pharmacy benefit manager (PBM) specializing in Medicare, Medicaid, and commercial health plans, and LucyRx, a PBM serving self-insured employers, labor groups, and specialty care networks. The merger, expected to finalize in the third quarter of 2026, aims to leverage complementary business strengths and technology platforms, including AI-driven tools like Darwin Healthcare Intelligence, to address evolving regulatory requirements such as state PBM transparency laws and the Consolidated Appropriations Act of 2026. Both companies emphasize scale without vertical integration to maintain trust and avoid conflicts of interest, positioning the combined entity to compete more effectively with major PBMs while anticipating further industry consolidation among smaller PBMs facing compliance challenges. pubtype: Periodical doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|